European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

Groupe Bruxelles Lambert Sa / Event-Driven

<ul>
<li>Vivendi's restated discount widened to 55.4%, while GBL moved to 27.6%; the former offers greater upside, but GBL retains the cleaner balance sheet and catalyst profile.</li>
<li>Porsche SE's discount held at 30.3%, but the final rejection of €5.4bn of investor claims removes a major legal tail risk without changing our NAV.</li>
<li>Investor and Industrivärden remain around or above NAV, while Rio's 23.1% Australian premium remains interesting mainly when the DLC spread moves towards historical extremes.</li>
</ul>


Vivendi's restated discount widened to 55.4%, while GBL moved to 27.6%; the former offers greater upside, but GBL retains the cleaner balance sheet and catalyst profile.
Porsche SE's discount held at 30.3%, but the final rejection of €5.4bn of investor claims removes a major legal tail risk without changing our NAV.
Investor and Industrivärden remain around or above NAV, while Rio's 23.1% Australian premium remains interesting mainly when the DLC spread moves towards historical extremes.


Selected European HoldCos and DLC: September 2026 Report

<ul>
<li>GBL and Porsche became more attractive in August as discounts widened to 26.4% and 30.2%, respectively, despite higher NAVs; Investor and Industrivärden remain above NAV.</li>
<li>Vivendi remains the valuation outlier at a 55.5% discount after July's court ruling removed mandatory-offer optionality, leaving substantial upside but no obvious near-term convergence catalyst.</li>
<li>Holding-Company valuations remain driven by governance, balance sheets and catalysts rather than historical averages: GBL offers the best balance, while Investor's premium leaves little margin of safety.</li>
</ul>


GBL and Porsche became more attractive in August as discounts widened to 26.4% and 30.2%, respectively, despite higher NAVs; Investor and Industrivärden remain above NAV.
Vivendi remains the valuation outlier at a 55.5% discount after July's court ruling removed mandatory-offer optionality, leaving substantial upside but no obvious near-term convergence catalyst.
Holding-Company valuations remain driven by governance, balance sheets and catalysts rather than historical averages: GBL offers the best balance, while Investor's premium leaves little margin of safety.


Selected European HoldCos and DLC: August 2026 Report

<ul>
<li>GBL’s discount tightened to 20.2%, versus &gt;40% at the beginning of 2025, as investors increasingly re-rate the structure toward a higher-quality capital allocation and private assets platform.</li>
<li>Updated SOTP incorporates both Rayner and BUKO investments. Private assets now represent ~38% of NAV, while GBL Capital accounts for a further 7.9%, preserving deployment flexibility.</li>
<li>With net cash now equivalent to ~2.4% of NAV, balance-sheet risk has largely disappeared. The investment case is shifting from deep-value convergence toward longer-duration NAV compounding and execution.</li>
</ul>


GBL’s discount tightened to 20.2%, versus &gt;40% at the beginning of 2025, as investors increasingly re-rate the structure toward a higher-quality capital allocation and private assets platform.
Updated SOTP incorporates both Rayner and BUKO investments. Private assets now represent ~38% of NAV, while GBL Capital accounts for a further 7.9%, preserving deployment flexibility.
With net cash now equivalent to ~2.4% of NAV, balance-sheet risk has largely disappeared. The investment case is shifting from deep-value convergence toward longer-duration NAV compounding and execution.


GBL Q1: Execution Continues, Discount Stabilises Near Multi-Year Lows

<ul>
<li>FY2025 results confirm GBL’s strategic repositioning. Our updated SOTP implies NAV €100.43 per share and a –21.4% discount, extending the steady re-rating underway since the –44% trough reached in mid-2024.</li>
<li>Portfolio structure continues to simplify. Listed assets represent ~47% of NAV while private platforms rise to ~34%, led by Affidea, Sanoptis and Rayner, increasing exposure to assets with operational influence.</li>
<li>Balance sheet remains conservative despite redeployment. Net leverage stays modest and buybacks continue, supporting gradual NAV-per-share accretion. Further discount compression likely incremental and execution-driven rather than catalyst-led.</li>
</ul>


FY2025 results confirm GBL’s strategic repositioning. Our updated SOTP implies NAV €100.43 per share and a –21.4% discount, extending the steady re-rating underway since the –44% trough reached in mid-2024.
Portfolio structure continues to simplify. Listed assets represent ~47% of NAV while private platforms rise to ~34%, led by Affidea, Sanoptis and Rayner, increasing exposure to assets with operational influence.
Balance sheet remains conservative despite redeployment. Net leverage stays modest and buybacks continue, supporting gradual NAV-per-share accretion. Further discount compression likely incremental and execution-driven rather than catalyst-led.


Groupe Bruxelles Lambert – FY2025 Results Update

<ul>
<li>GBL completes full Umicore exit and adds Rayner, materially advancing portfolio simplification and private healthcare exposure; discount continues its structural tightening from mid-2024 stress levels.</li>
<li>Updated SOTP reflects improved asset mix and conservative funding; balance-sheet strength remains intact as capital recycling becomes tangible rather than rhetorical.</li>
<li>Re-Rating phase maturing: further discount compression likely execution-driven, not narrative-driven. Positioning shifts from high-beta convergence trade to steadier credibility-led tightening thesis.</li>
</ul>


GBL completes full Umicore exit and adds Rayner, materially advancing portfolio simplification and private healthcare exposure; discount continues its structural tightening from mid-2024 stress levels.
Updated SOTP reflects improved asset mix and conservative funding; balance-sheet strength remains intact as capital recycling becomes tangible rather than rhetorical.
Re-Rating phase maturing: further discount compression likely execution-driven, not narrative-driven. Positioning shifts from high-beta convergence trade to steadier credibility-led tightening thesis.


GBL: From Stress Discount to Structural Repair

Belgium

Groupe Bruxelles Lambert S.A. is a holding company with interests in energy, media, and utility companies.  The Company, through its subsidiaries, produces petroleum, manufactures chemicals, operates gasoline filling stations, owns and operates television and radio stations, supplies water, generates and transports electricity, transports natural gas, and offers waste management services.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Groupe Bruxelles Lambert Sa (GBLB BB)

Selected European HoldCos and DLC: September 2026 Report

Wide discounts, persistent premiums and shifting catalysts. We revisit Europe's main holding-company valuation gaps and where the next convergence...

Jesus Rodriguez Aguilar

Selected European HoldCos and DLC: August 2026 Report

GBL and Porsche cheapened in August, while Investor remains above NAV. Vivendi's 55.5% discount offers the largest upside, but July's court ruling...

Jesus Rodriguez Aguilar

GBL Q1: Execution Continues, Discount Stabilises Near Multi-Year Lows

GBL’s discount continues to tighten as private assets rise to 38% of NAV and balance-sheet risk disappears. Shares increasingly trade on execution...

Jesus Rodriguez Aguilar

Groupe Bruxelles Lambert – FY2025 Results Update

GBL’s FY2025 results confirm continued portfolio execution and discount repair. The holding company has rerated sharply since mid-2024, but the...

Jesus Rodriguez Aguilar

GBL: From Stress Discount to Structural Repair

GBL exits Umicore and adds Rayner, advancing simplification and private healthcare exposure. The discount has halved since 2024; further tightening...

Jesus Rodriguez Aguilar

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)